SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mankind Pharma informs about investors meet

07 Aug 2024 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Mankind Pharma has informed that the management and officials of the Company will be meeting with various investors in person in Singapore on August 14, 2024 to August 15, 2024. During the meeting with investors/analysts no unpublished price sensitive information (‘UPSI’) shall be disclosed which is not already available in public domain. The discussion would be based on the general business outlook and information which is already in public domain.

The above information is a part of company’s filings submitted to BSE.


Mankind Pharma Share Price

2267.15 -24.70 (-1.08%)
24-Apr-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.50
Dr. Reddys Lab 1312.40
Cipla 1295.00
Zydus Lifesciences 930.00
Lupin 2285.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×